Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynda A Morrison

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Drugs|May 16, 2002
Vaccines against genital herpes: progress and limitationsLynda A Morrison
Virology|April 16, 2008
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cellsLynda A Morrison
Trends in Microbiology|July 28, 2004
The Toll of herpes simplex virus infectionLynda A Morrison
Antiviral Research|June 18, 2018
Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in miceKaelin M Bernier, Lynda A Morrison
Virology|April 6, 2004
Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsivenessRebecca J Duerst, Lynda A Morrison
Journal of Virology|January 29, 2003
Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulationLydia G Thebeau, Lynda A Morrison
Journal of Virology|February 12, 2002
B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathologyLydia G Thebeau, Lynda A Morrison
Viral Immunology|January 22, 2004
Innate immunity to herpes simplex virus type 2Rebecca J Duerst, Lynda A Morrison
Virology|December 13, 2006
Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase LRebecca J Duerst, Lynda A Morrison
Nucleus (Austin, Tex.)|September 24, 2011
Breach of the nuclear lamina during assembly of herpes simplex virusesLynda A Morrison, Gregory S DeLassus
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Drugs|May 16, 2002
Vaccines against genital herpes: progress and limitationsLynda A Morrison
Virology|April 16, 2008
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cellsLynda A Morrison
Trends in Microbiology|July 28, 2004
The Toll of herpes simplex virus infectionLynda A Morrison
Antiviral Research|June 18, 2018
Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in miceKaelin M Bernier, Lynda A Morrison
Virology|April 6, 2004
Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsivenessRebecca J Duerst, Lynda A Morrison
Journal of Virology|January 29, 2003
Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulationLydia G Thebeau, Lynda A Morrison
Journal of Virology|February 12, 2002
B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathologyLydia G Thebeau, Lynda A Morrison
Viral Immunology|January 22, 2004
Innate immunity to herpes simplex virus type 2Rebecca J Duerst, Lynda A Morrison
Virology|December 13, 2006
Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase LRebecca J Duerst, Lynda A Morrison
Nucleus (Austin, Tex.)|September 24, 2011
Breach of the nuclear lamina during assembly of herpes simplex virusesLynda A Morrison, Gregory S DeLassus
Pageof 6